Facebook
Twitter
RSSUS rescind approval for Avastin
21st November 2011US drug regulators say Avastin is not effective enough to justify risks of taking it.
Click on available sources in right hand menu to see the original article.
Share this page
Comments
chelsey wayne
Wednesday 23rd November 2011 @ 8:31
Avastin is a cancer drug manufactured by Genentech, a part of Roche Pharmaceuticals. The Food and Drug Administration approval for Avastin was conditional. The Food and Drug Administration allowed it to be used only pending certain studies. Now that those studies have been finished, the approval has been taken away. Here is the proof: Approval pulled for Avastin breast cancer drug
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Article Information
Title: US rescind approval for Avastin
Author:
Martine Hamilton
Article Id: 20380
Date Added: 21st Nov 2011
Sources
Recent Related Articles
Breast cancer screening recall
Under-50s breast cancer tops 10,000 a year
Fraudulent Botox found in the US
NHS Scotland chief leaves for US
Melanoma survivors not using sunscreen
Skin cancer rising in US children
NICE rejects advanced breast cancer drug
One in 50 children in the US has autism
One in three seniors in US die with dementia
Man in US dies of rabies
